This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Investment Opportunities

Filter
  • Stage
  • Sector

Capital at Risk. Please read our risk warning and disclaimer

There was a problem loading the results. Try again?
overfunding
  • EIS
9 days left

The Five Points Brewing Company

The Five Points is one of London's best known craft breweries. Now selling over 2 million pints annually their flavourful, unfiltered beers are stocked nationwide in Waitrose and exported. Averaging growth of over 100% annually since launch, they are funding to treble capacity and open 1st Taproom.

£750,000 Target
119%
Raised
£899,410
Equity
6.71%
Investors
1,273
overfunding
  • EIS
1 day left

Midrive

Midrive is reinventing driving and insurance for the digital generation. In the last 12 months, monthly revenue from their 'pay as you go' hourly insurance and 'app-powered' lessons has increased 391%. Double-gold rated investment on CrowdRating.co.uk and backed by Initial Capital.

£1,800,000 Target
120%
Raised
£2,170,040
Equity
17.83%
Investors
709
14 days left

MAM Originals

MAM Originals is an ethical wood watch brand. In 2017 the company sold 35,000+ watches through its website and generated over €2.3M in sales and €38k EBITDA. MAM's main goal this year is to open multi-brand stores, which make up the majority of sales in the watch industry and generated €230k+ in revenue in Q4 2017 alone.

£200,000 Target
74%
Raised
£149,010
Equity
3.68%
Investors
88
  • EIS
11 days left

Redemption

Redemption is the "world’s healthiest bar restaurant" (Metro) - a place where socialising isn't at the expense of health or planet: 100% vegan, alcohol-free, sugar-free, wheat-free. It has two sites in Notting Hill and Shoreditch, and is raising funds to open two more locations in central London.

£300,000 Target
55%
Raised
£166,790
Equity
10.71%
Investors
200
  • EIS
28 days left

Cell Guidance Systems

Cell Guidance Systems is developing a patented technology to unlock the medical potential of growth factor proteins. PODS enables proteins to treat diseases, such as Parkinson's disease and osteoarthritis, by improving their delivery to the disease site. The technology addresses multi-$bn markets.

£500,000 Target
60%
Raised
£300,550
Equity
5.13%
Investors
107
overfunding
  • EIS
22 days left

Lightly Technologies

Lightly Technologies has developed a patent-pending, ultra-thin LED light bulb, enabling a new generation of lighting fixture design and lighting in architecture. With a growing customer base across Europe, our technology is used to create exceptional experiences with light.

£250,000 Target
136%
Raised
£340,070
Equity
17.99%
Investors
465
  • EIS
20 days left

OWNTHELOOK.COM

OWNTHELOOK.COM is an online global womenswear store focusing on outfit dressing for the everyday woman. Launched in March ‘17 with over 40 emerging brands, they were titled “The new ASOS” by industry experts and have been featured widely in the media including Vogue, InStyle, and The Telegraph.

£175,000 Target
94%
Raised
£165,240
Equity
17.50%
Investors
159
overfunding
4 days left

E-Sign

E-Sign is an electronic signature service providing secure, encrypted document storage facilities with full audit trail and digital signatory ID validation. The company has achieved 300% annual turnover increase for the last 3 years and is a UK government registered digital strategies specialist.

£75,000 Target
219%
Raised
£164,430
Equity
12.05%
Investors
302
overfunding
  • EIS
Last day

TeachPitch

TeachPitch solves the problem of information abundance for teachers and schools. The company’s software is used in hundreds of schools, is partnering with a major Education company in China and has started to certify its users to provide online tutoring to other educators on the platform.

£300,000 Target
121%
Raised
£365,230
Equity
7.21%
Investors
265
There was a problem loading the results. Try again?

Risk warning

Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated.

Please click here to read the full risk warning. This page is approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Crowdcube takes no responsibility for this information or for any recommendations or opinions made by the companies.

The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.